Studies involving disease:Cancer
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST000010 | Lung Cancer Cells 4 | Human | University of Michigan |
| ST000044 | Pilot experiment looking for the existence of certain molecules in pancreatic cancer cells | Human | University of Michigan |
| ST000054 | Metabolic Microenvironments in Normal Breast and Breast Cancer (MS analysis) | Human | University of North Carolina |
| ST000058 | Metabolite changes associated with methionine stress sensitivity of cancer (GC TOF MS analysis) | Human | University of California, Davis |
| ST000065 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: GC-TOF MS analyis of serum samples | Human | University of California, Davis |
| ST000077 | Metabolite changes associated with methionine stress sensitivity of cancer (CSH QTOF MS analysis) | Human | University of California, Davis |
| ST000081 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of subcutaneous and visceral adipose tissue samples | Human | University of California, Davis |
| ST000082 | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of serum samples | Human | University of California, Davis |
| ST000087 | A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: GC-TOF MS analysis | Human | University of California, Davis |
| ST000089 | A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis | Human | University of California, Davis |
| ST000096 | A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UPLC-QTRAP MS analysis | Human | University of California, Davis |
| ST000104 | Factors for Epigenetic Silencing of Lung Cancer Genes | Human | University of North Carolina |
| ST000113 | SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Positive ion mode FTMS) | Human | University of Kentucky |
| ST000114 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | Human | University of Kentucky |
| ST000133 | 1H NMR Metabolomics Study of Metastatic Melanoma in C57BL/6J Mouse Spleen | Mouse | Pacific Northwest National Laboratory |
| ST000134 | Monitoring In Vitro Response of Selenium-Treated Prostate Cells by 1H NMR Spectroscopy | Human | Purdue University |
| ST000142 | H1299 13C-labeled Cell Study | Human | University of Kentucky |
| ST000144 | Primary T Cell Baseline (Donor 5) - II | Human | University of Michigan |
| ST000145 | Primary T Cell Noxa Knockdown (Donor 8) | Human | University of Michigan |
| ST000146 | Noxa regulation of malate aspartate shuttle | Human | University of Michigan |
| ST000148 | A549 13C-labeled Cell Study | Human | University of Kentucky |
| ST000153 | Primary T Cell Noxa Knockdown (Donor 8)-II | Human | University of Michigan |
| ST000220 | Small cell lung cancer metabolome (part II) | Human | University of North Carolina |
| ST000221 | Normal plasma cells,Low proliferation multiple myeloma and High proliferation multiple myeloma cells | Human | Mayo Clinic |
| ST000230 | Comprehensive analysis of transcriptome and metabolome in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma | Human | Osaka City University |
| ST000231 | Comprehensive analysis of transcriptome and metabolome in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma (part II) | Human | Osaka City University |
| ST000248 | Metabolic heterogeneity in Glioblastoma | Human | University of Florida |
| ST000276 | IDH1 and Glioma knockdown idh1 | Human | University of Michigan |
| ST000285 | NMR-based Metabolomics for CRC Diagnosis | Human | University of Washington |
| ST000312 | IDH1R132H activity in glioma cell lines and tumnor tissue (2HG) | Mouse | University of Michigan |
| ST000341 | Methylation in mouse lymphomas | Mouse | University of Florida |
| ST000355 | GC/MS and LC/MS metabolomics profiling for breast cancer plasma data and control plasma data | Human | University of Hawaii |
| ST000356 | GC/MS and LC/MS metabolomics profiling for breast cancer serum data and control serum data | Human | University of Hawaii |
| ST000366 | Metabolomics analysis of colon adenoma in African Americans | Human | University of North Carolina |
| ST000367 | Distinctly perturbed metabolic networks underlie differential tumor tissue damages induced by immune modulator b-glucan in a two-case ex vivo non-small cell lung cancer study | Human | University of Kentucky |
| ST000368 | Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer | Human | University of California, Davis |
| ST000369 | Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer (part II) | Human | University of California, Davis |
| ST000371 | Colon cancer metabolomics via stool sample | Mouse | University of Michigan |
| ST000385 | Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer (training set) | Human | University of California, Davis |
| ST000386 | Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer (test/validation) | Human | University of California, Davis |
| ST000388 | Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer (part I) | Human | University of California, Davis |
| ST000389 | Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer (part II) | Human | University of California, Davis |
| ST000390 | Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma (part I) | Human | University of California, Davis |
| ST000391 | Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma (part II) | Human | University of California, Davis |
| ST000392 | Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry | Human | University of California, Davis |
| ST000396 | Lung Cancer Plasma Discovery | Human | University of California, Davis |
| ST000404 | Role of HVCN1 in B cell malignancies | Human | University of California, Davis |
| ST000438 | Characterizing commonalities and differences between the breast and prostate cancer metabotypes in African-American cohorts (part I) | Human | University of North Carolina |
| ST000439 | Characterizing commonalities and differences between the breast and prostate cancer metabotypes in African-American cohorts | Human | University of North Carolina |
| ST000442 | Metabolomics Analysis of Triple Negative Breast Cancer (BCa) Cell Lines | Human | University of North Carolina |
| ST000454 | Utilizing Metabolomics to Understand Novel Anti-Desmoid Tumor Drugs (part I) | Human | RTI International |
| ST000455 | Utilizing Metabolomics to Understand Novel Anti-Desmoid Tumor Drugs (part II) | Human | RTI International |
| ST000458 | Effect of BCAT1 knockdown on amino acid steady state levels of Raji cells | Human | University of Florida |
| ST000459 | Effect of Odc knockout on amino acid steady state levels of Eμ-Myc lymphomas | Mouse | University of Florida |
| ST000460 | Effect of ATG7 reconstitution in AGY571 cells | Mouse | University of Florida |
| ST000461 | Effect of Odc knockout on amino acid homeostasis of Eu-Myc Lymphomas | Mouse | University of Florida |
| ST000465 | Uniquely Tumor-Selective Englerin A Profoundly Alters Lipid Metabolism in Renal Cell Carcinoma inducing ER-Stress and an Acute Inflammatory Response | Human | University of California, San Diego |
| ST000474 | Metabolomic testing of a putative MDH inhibitor (targeted) | Human | University of Florida |
| ST000475 | Metabolomic testing of a putative MDH inhibitor (global) | Human | University of Florida |
| ST000494 | Timecourse of palmitate isotopomers in LNCaP Cells | Human | Mayo Clinic |
| ST000504 | Timecourse of TCA isotopomers in LNCaP Cells and Media | Human | Mayo Clinic |
| ST000505 | Timecourse of Amino Acid Metabolites in LNCaP Cell pellets | Human | Mayo Clinic |
| ST000506 | Timecourse of TCA panel in LNCaP Cells | Human | Mayo Clinic |
| ST000507 | Timecourse of TCA isotopomers in LNCaP Cells | Human | Mayo Clinic |
| ST000528 | Regulation of Metabolism by LSR | Human | University of North Carolina |
| ST000529 | Regulation of Metabolism by LSR (part II) | Human | University of North Carolina |
| ST000548 | Replication study: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate | Human | University of California, Davis |
| ST000574 | Effects of the Kinase Inhibitor Sorafenib on Serum Metabolism In Vivo using Non-targeted Metabolomics Analysis tissue). | Mouse | University of North Carolina at Chapel Hill |
| ST000575 | Effects of the Kinase Inhibitor Sorafenib on Muscle Metabolism In Vivo using Non-targeted Metabolomics Analysis tissue). | Mouse | University of North Carolina at Chapel Hill |
| ST000576 | Effects of the Kinase Inhibitor Sorafenib on Heart Metabolism In Vivo using Non-targeted Metabolomics Analysis tissue). | Mouse | University of North Carolina at Chapel Hill |
| ST000577 | Effects of the Kinase Inhibitor Sorafenib on Liver Metabolism In Vivo using Non-targeted Metabolomics Analysis tissue). | Mouse | University of North Carolina at Chapel Hill |
| ST000611 | Relative level of inosine/adenosine and sarcosine | Human | Baylor College of Medicine |
| ST000614 | Tobacco-specific carcinogens in Bladder Cancer | Human | Baylor College of Medicine |
| ST000615 | GC/MS measurement of sarcosine in urine samples | Human | Baylor College of Medicine |
| ST000642 | Trace 13C-glucose, 13C-glutamine, and 13C-serine in genetically engineered pancreatic cell lines through free fatty acids (part I) | Human | Mayo Clinic |
| ST000643 | Trace 13C-glucose, 13C-glutamine, and 13C-serine in genetically engineered pancreatic cell lines through non-esterified fatty acids (part II) | Human | Mayo Clinic |
| ST000644 | Trace 13C-glucose, 13C-glutamine, and 13C-serine in genetically engineered pancreatic cell lines through ceramides (part III) | Human | Mayo Clinic |
| ST000713 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm | Human | University of Michigan |
| ST000714 | Effect of genetic lesions on glioblastoma (NP, NPA, NPAI, NS) | Mouse | University of Michigan |
| ST000727 | Bariatric surgery and breast cancer | Mouse | University of Michigan |
| ST000728 | Effects of bariatric and antibiotic treatment surgery on mammary carcinogenesis | Mouse | University of Michigan |
| ST000740 | Quantitating the baseline fatty acid composition in phospholipids in subgroups of tumor cells | Human | University of Michigan |
| ST000782 | Nuclear magnetic resonance-based metabolomics approach to evaluate the prevention effect of Camellia nitidissima Chi on colitis-associated carcinogenesis | Mouse | Nanjing University of Science & Technology |
| ST000783 | Absolute Quantification of 180 metabolites in serum from african american and european american in prostate cancer and case control samples | Human | Baylor College of Medicine |
| ST000784 | metabolome in a group of AA and EA matched pairs of prostate cancer (PCa) and benign adjacent tissues | Human | Baylor College of Medicine |
| ST000787 | Identifying metabolic adaptations characteristic of multiple myeloma cells via mass spectrometry-based metabolite profiling from Peripheral Plasma | Human | Mayo Clinic |
| ST000788 | Identifying metabolic adaptations characteristic of multiple myeloma cells via mass spectrometry-based metabolite profiling from Bone Marrow Plasma | Human | Mayo Clinic |
| ST000789 | Identifying metabolic adaptations characteristic of multiple myeloma cells via mass spectrometry-based metabolite profiling from (CD138+ Plasma Cells) | Human | Mayo Clinic |
| ST000790 | Identifying metabolic adaptations characteristic of multiple myeloma cells via targeted sphingolipids concentrations from bone marrow and peripheral plasma | Human | Mayo Clinic |
| ST000791 | Identifying metabolic adaptations characteristic of multiple myeloma cells via amino acids concentrations from bone marrow plasma | Human | Mayo Clinic |
| ST000820 | 2 hydroxyglutarate prodution in neurospheres from IDH1 mouse glioma model #2 | Mouse | University of Michigan |
| ST000821 | Metabolomic profiling of IDH1 mutation | Human | University of Michigan |
| ST000822 | Metabolomic profiling of IDH1 mutation (part II) | Human | University of Michigan |
| ST000823 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) | Human | University of Michigan |
| ST000824 | 2HG concentration in human IDH1m cells | Human | University of Michigan |
| ST000865 | Identification of Race-Associated Metabolite Biomarkers for Hepatocellular Carcinoma | Human | Georgetown University |
| ST000893 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Metabolism In Vivo | Mouse | University of North Carolina at Chapel Hill |
| ST000894 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Liver Metabolism In Vivo | Mouse | University of North Carolina at Chapel Hill |
| ST000895 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Serum Metabolism In Vivo using Non-Targeted Metabolomics Analysis | Mouse | University of North Carolina at Chapel Hill |
| ST000896 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Muscle Metabolism In Vivo | Mouse | University of North Carolina at Chapel Hill |
Return to search page
